Dr Albert L Hirsch Jr, MD | |
5952 Royal Ln Ste 204, Dallas, TX 75230 | |
(214) 421-1188 | |
(214) 421-2410 |
Full Name | Dr Albert L Hirsch Jr |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 5952 Royal Ln Ste 204, Dallas, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861404477 | NPI | - | NPPES |
8B0280 | Other | TX | BCBS |
0009GN | Other | TX | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | F4732 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Albert L Hirsch Jr, MD 5952 Royal Ln Ste 204, Dallas, TX 75230-7853 Ph: (214) 421-1188 | Dr Albert L Hirsch Jr, MD 5952 Royal Ln Ste 204, Dallas, TX 75230 Ph: (214) 421-1188 |
News Archive
Helping social workers face the ethical challenges of social media is up for discussion this Friday (17 October) at Social Work in Health in the 21st Century: Innovating, Influencing, Integrating.
This intriguing question is at the heart of a new study based on an "experiment of nature" being conducted by Wellcome Trust-funded researchers.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of TafinlarĀ® in combination with MekinistĀ® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
With this decision, U.S. District Court Judge Roger Vinson issued the first opinion to strike down the entire health overhaul as various legal challenges to the sweeping measure continue to wind their way to the Supreme Court.
Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
› Verified 5 days ago
Mazen Hassan, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave Ste 550, Dallas, TX 75246 Phone: 214-821-1177 | |
Anne Marie Brancaccio, MD General Practice Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8600 | |
Patrick Kasong Muyej, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9030 Markville Dr Apt 2735, Dallas, TX 75243 Phone: 469-841-8023 | |
Athol John Ware, MB BS MD General Practice Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-2992 Fax: 214-648-2087 | |
Dr. Monique Michelle Antoine, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4055 Valley View Ln Ste 400, Dallas, TX 75244 Phone: 469-466-7168 | |
Janet Turner, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 5917 Belt Line, Dallas, TX 75254 Phone: 972-972-6646 | |
Dr. John Stuart Scott, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-6400 Fax: 214-648-5461 |